ClassID:

21647

A61K2300/00 - page 85 - CPC Classification

Classification description:

Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups  - 

Recent Application in this class:
#25201
20050085437
2005-04-21

Crystalline drug form

#25202
20050085431
2005-04-21

Treatment of hypertension

#25203
20050085430
2005-04-21

Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease

#25204
20050085428
2005-04-21

Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a methylxanthine derivative for treatment of asthma or chronic obstructive pulmonary disease

#25205
20050085416
2005-04-21

Biologically active complex

#25206
20050085414
2005-04-21

Medical use for tachykinin antagonists

#25207
20050084553
2005-04-21

Composition containing moutan root bark extract as active ingredient

#25208
20050084552
2005-04-21

Pharmaceutical composition of chinese herbs for treating snuffle, headache and the use thereof

#25209
20050084547
2005-04-21

Natural product based apoptosis inducers

#25210
20050084546
2005-04-21

Antioxidant and antiactinic tea plant products

#25211
20050084524
2005-04-21

Method for potentiating activity of a chemotherapeutic drug

#25212
20050084514
2005-04-21

Combination drug therapy for reducing scar tissue formation

#25213
20050084501
2005-04-21

Therapeutic agent for a cancer and method of screening the same, and health-care auxillary food

#25214
20050084500
2005-04-21

Growth promoter composition for animals

#25215
20050084490
2005-04-21

Boroproline compound combination therapy

#25216
20050084489
2005-04-21

Methods of preventing or treating disorders by administering and integrin alphanubeta3 antagonist in combination with an HMG-CoA reductase inhibitor or a bisphosphonate

#25217
20050084486
2005-04-21

Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product

#25218
20050084473
2005-04-21

Treatment of acne by topical herbal extract solution

#25219
20050084454
2005-04-21

Compositions and methods for cleaning nasal cavities

#25220
20050080122
2005-04-14

Anti-viral compounds

#25221
20050080109
2005-04-14

Gamma-tocopherol and gamma-tocotrienol therapy for multiple sclerosis

#25222
20050080099
2005-04-14

Methods and kits for treating depression or preventing deterioration of cognitive function

#25223
20050080084
2005-04-14

Compositions of a cyclooxygenase-2 selective inhibitor and a serotonin-modulating agent for the treatment of central nervous system damage

#25224
20050080083
2005-04-14

Compositions of a cyclooxygenase-2 selective inhibitor and an angiotensin II receptor antagonist for the treatment of central nervous system damage

#25225
20050080071
2005-04-14

Treatment methods

#25226
20050080069
2005-04-14

Anticancer agent

#25227
20050080062
2005-04-14

Breast cancer treatment regimen

#25228
20050080061
2005-04-14

Antiglucocorticoid therapy for the prevention of neurological damage in premature infants

#25229
20050080056
2005-04-14

Ophthalmic formulations including selective alpha 1 antagonists

#25230
20050080052
2005-04-14

Anti-asthmatic combinations comprising surface active phospholipids

#25231
20050080051
2005-04-14

Charged phospholipid compositions and methods for their use

#25232
20050080045
2005-04-14

Composition comprising dextrinsulfate for the treatment of sexual transmitted diseases (std)

#25233
20050080038
2005-04-14

Vaginal pharmaceutical compositions and methods for preparing them

#25234
20050080037
2005-04-14

Methods for treating acute and overuse sprain and strain using hyaluronic acid

#25235
20050080035
2005-04-14

Use of BVDU for inhibiting the growth of hyperproliferative cells

#25236
20050080017
2005-04-14

Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

#25237
20050080011
2005-04-14

Stabilization of pharmaceutical protein formulations with small peptides

#25238
20050080008
2005-04-14

Antithrombotic materials and methods

#25239
20050080006
2005-04-14

ApO2 ligand/TRAIL formulations

#25240
20050079998
2005-04-14

Compositions and methods for modulating serum cholesterol

#25241
20050079597
2005-04-14

Antimicrobial composition

#25242
20050079543
2005-04-14

Receptor recognition factors, protein sequences and methods of use thereof

#25243
20050079235
2005-04-14

Use of a polyphenol for the treatment of actinic keratosis

#25244
20050079234
2005-04-14

Compositions comprising herbs and method for immunomodulation

#25245
20050079228
2005-04-14

Clear, stable topical compositions of clarithromycin and processes for their preparation

#25246
20050079225
2005-04-14

Methods and therapeutic compositions in the treatment of advanced cancer

#25247
20050079178
2005-04-14

Inhibitor of cardiac tachyarrhythmias

#25248
20050079174
2005-04-14

Methods and compositions for immunotherapy of B cell involvement in promotion of a disease condition comprising multiple sclerosis

#25249
20050079172
2005-04-14

Methods and compositions for inducing apoptosis in cancer cells

#25250
20050079164
2005-04-14

Solubilized CoQ-10 and carnitine

#25251
20050079162
2005-04-14

Method for improving oxygen transport by stored red blood cells

#25252
20050079158
2005-04-14

Construct of anti-cancer recombinant adenovirus, method for preparing the same and use thereof

#25253
20050079157
2005-04-14

Combination bacteriolytic therapy for the treatment of tumors

#25254
20050079156
2005-04-14

Method of treating endometreosis

#25255
20050079153
2005-04-14

Methods for enhancing immune functions in neonatal mammals by administration of IL-18

#25256
20050079140
2005-04-14

Toothpaste formulation with green tea extract and fluoride

#25257
20050079139
2005-04-14

Minoxidil pharmaceutical foam formulation

#25258
20050075396
2005-04-07

Use of (-)(3-trihalomethylphenoxy)(4-halophenyl) acetic acid derivatives for treatment of insulin resistance, Type 2 diabetes and hyperlipidemia

#25259
20050075391
2005-04-07

Nitric oxide donor composition and method for treatment of anal disorders

#25260
20050075358
2005-04-07

Methods for treating IGF1R-inhibitor induced hyperglycemia

#25261
20050075343
2005-04-07

Benzimidazole derivatives as modulators of IgE

#25262
20050075341
2005-04-07

Compositions of a cyclooxygenase-2 selective inhibitor and an IKK inhibitor for the treatment of ischemic mediated central nervous system disorders or injury

#25263
20050075329
2005-04-07

Compositions and methods for treating or preventing convulsions or seizures

#25264
20050075321
2005-04-07

Neurological disorder treatment methods

#25265
20050075313
2005-04-07

Ophthalmic compositions containing galactomannan polymers and borate

#25266
20050075310
2005-04-07

Gangliosides with a modified acyl function

#25267
20050075301
2005-04-07

Pharmaceutical preparation with RNA as hemostasis cofactor

#25268
20050075296
2005-04-07

Injectable compositions for the controlled delivery of pharmacologically active compound

#25269
20050075295
2005-04-07

Combination comprising combretastatin and anticancer agents

#25270
20050075282
2005-04-07

Materials and methods for inhibiting the development of epilepsy

#25271
20050075277
2005-04-07

Use of lactoferrin in prophylaxis against infection and/or inflammation in immunosuppressed subjects

#25272
20050075276
2005-04-07

Use of inhibitors of glycogen synthase-3 to augment CD28 dependent -T-cell responses

#25273
20050074882
2005-04-07

Methods and products related to metabolic interactions in disease

#25274
20050074875
2005-04-07

Induction of tubular morphogenesis using pleiotrophin

#25275
20050074866
2005-04-07

Biologically stable liquid composition of FVIII, of vWF or of FVIII/vWF complex of human origin

#25276
20050074836
2005-04-07

Factor VII polypeptide having factor VII:C activity

#25277
20050074830
2005-04-07

Detection of sphingosine kinase activity and sphingosine kinase agonist or antagonist activity

#25278
20050074743
2005-04-07

Method and composition for treating a biological sample

#25279
20050074510
2005-04-07

Topical preparations for use in treatment of anorectal disease

#25280
20050074509
2005-04-07

Cancer treatment using natural plant products or essential oils extracted from some pistacia species or components

#25281
20050074507
2005-04-07

Polyherbal formulation for hepatic and splenic disorders

#25282
20050074505
2005-04-07

Calcium zeolite hemostatic agent

#25283
20050074503
2005-04-07

Bilious balsam

#25284
20050074501
2005-04-07

Apparatus and method for administering a therapeutic agent into tissue

#25285
20050074481
2005-04-07

Device for regeneration of articular cartilage and other tissue

#25286
20050074462
2005-04-07

Supression of allergic reactions by transdermal administration of allergens conjugated to cholera toxin or fragments thereof

#25287
20050074454
2005-04-07

Methods of treating carcinoma using anti-TNF antibodies and peptides

#25288
20050074453
2005-04-07

Methods of preventing adhesions following laminectomies and other surgical procedures

#25289
20050074451
2005-04-07

Methods and compositions for treating rheumatoid arthritis

#25290
20050074447
2005-04-07

Treatment for diabetic microvascular and macrovascular complications

#25291
20050074446
2005-04-07

Gamma-tocopherol treatment for cystic fibrosis

#25292
20050074445
2005-04-07

Alpha-tocopherol treatment for cystic fibrosis

#25293
20050074444
2005-04-07

Coenzyme Q10 treatment for cystic fibrosis

#25294
20050074443
2005-04-07

Methods of attenuating autoimmune disease and compositions useful therefor

#25295
20050074442
2005-04-07

Compositions and methods for augmenting kidney function

#25296
20050074429
2005-04-07

Compositions comprising IMPDH inhibitors and uses thereof for treating HCV infection

#25297
20050074428
2005-04-07

Adjuvant agent for hepatitis C

#25298
20050074425
2005-04-07

Method for delivering polymerized therapeutic agent compositions and compositions thereof

#25299
20050074412
2005-04-07

Irrigating fluid

#25300
20050070877
2005-03-31

Compositions and methods of using lamellar bodies for modifying linear biological macromolecules

#25301
20050070720
2005-03-31

11-β-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia

#25302
20050070612
2005-03-31

Methods and compositions for inhibiting the proliferation of prostate cancer cells

#25303
20050070608
2005-03-31

Pharmaceutical compositions and method of using levodopa and carbidopa

#25304
20050070604
2005-03-31

Inhibition of exoprotein production using isoprenoid compositions

#25305
20050070594
2005-03-31

Use of angiotensin II receptor antagonists

#25306
20050070590
2005-03-31

Xanthone derivatives, method of production thereof, and pharmaceutical composition containing the same

#25307
20050070577
2005-03-31

Compositions containing a serotonin selective reuptake inhibitor and a 5-HT2A receptor antagonist

#25308
20050070569
2005-03-31

Alkyne-aryl phosphodiesterase-4 inhibitors

#25309
20050070557
2005-03-31

Treatment of insulin resistance syndrome and type 2 diabetes with PDE9 inhibitors

#25310
20050070553
2005-03-31

Pharmaceutical composition comprising an alpha-glucosidase inhibitor and a 4-oxobutanoic acid, and the use thereof for treating diabetes

#25311
20050070543
2005-03-31

Compositions of a chromene or phenyl acetic acid cyclooxygenase-2 selective inhibitor and an ACE inhibitor for the treatment of central nervous system damage

#25312
20050070537
2005-03-31

Use of dihydroimidazolones for the treatment of dogs

#25313
20050070524
2005-03-31

Compositions of a cyclooxygenase-2 selective inhibitor and an anticonvulsant agent for the treatment of central nervous system disorders

#25314
20050070516
2005-03-31

As-needed administration of an androgenic agent to enhance female desire and responsiveness

#25315
20050070512
2005-03-31

Pharmaceutical composition and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and an estrogen agonist/antagonist

#25316
20050070510
2005-03-31

Substituted tetracycline compounds as synergistic antifungal agents

#25317
20050070498
2005-03-31

Enteral formulation

#25318
20050070489
2005-03-31

Use of dsrnas in strategic therapeutic intervention of highly active antiretroviral therapy

#25319
20050070487
2005-03-31

Composition, formulations and kit for treatment of respiratory and lung disease with non-glucocorticoid steroids and/or ubiquinone and a bronchodilating agent

#25320
20050070477
2005-03-31

Compositions for treatment and prevention of pulmonary conditions

#25321
20050070467
2005-03-31

Antitumor agent

#25322
20050069985
2005-03-31

Assay methods and amelioration of muscular dystrophy symptoms

#25323
20050069960
2005-03-31

Novel complementing receptor-ligand pairs and adoptive immunotherapy using the same

#25324
20050069598
2005-03-31

Methods for treating disorders using plant extracts

#25325
20050069597
2005-03-31

Method of using a compound of menthol and L-arginine as a preparation for the topical delivery of alprostadil for the treatment of female sexual dysfunction

#25326
20050069596
2005-03-31

Compositions and methods comprising kava and anti-anxiety compounds

#25327
20050069595
2005-03-31

Nitric oxide in treatment of inflammation

#25328
20050069593
2005-03-31

Nutritional supplement containing 7-Keto-DHEA and conjugated linoleic acid

#25329
20050069584
2005-03-31

Diphenhydramine tannate solid dose compositions and methods of use

#25330
20050069583
2005-03-31

Compositions

#25331
20050069580
2005-03-31

Compositions containing both sedative and non-sedative antihistamines and sleep aids

#25332
20050069555
2005-03-31

Thiosemicarbazones as anti-virals and immunopotentiators

#25333
20050069541
2005-03-31

Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents

#25334
20050069535
2005-03-31

Immunotherapeutic combinations for the treatment of tumours that overexpress gangliosides

#25335
20050069526
2005-03-31

Promoting Recovery from Damage to the Central Nervous System

#25336
20050069522
2005-03-31

Combination pharmaceutical agents as inhibitors of HCV replication

#25337
20050069520
2005-03-31

Methods and compositions for treating mammalian nerve tissue injuries

#25338
20050069518
2005-03-31

Method for treating occlusive vascular diseases & wound healing

#25339
20050069505
2005-03-31

Orally administrable composition for the photoprotection of the skin

#25340
20050065319
2005-03-24

Combination method for treating viral infections

#25341
20050065205
2005-03-24

Methods for Alzheimer's disease treatment and cognitive enhance

#25342
20050065202
2005-03-24

Use of sulphonamide derivatives for the manufacture of a medicament for the prophylaxis and/or treatment of disorders of food ingestion

#25343
20050065196
2005-03-24

Azole compound and medicinal use thereof

#25344
20050065192
2005-03-24

Methods and compositions for treating rheumatoid arthritis

#25345
20050065190
2005-03-24

Comprehensive pharmacologic therapy for treatment of obesity including cysteine

#25346
20050065180
2005-03-24

Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and a growth hormone secretagogue

#25347
20050065176
2005-03-24

Combinations

#25348
20050065158
2005-03-24

Treatment of sexual dysfunction

#25349
20050065154
2005-03-24

Treatment of migraine accompanied by nausea with a combination of cyclooxygenase-2 selective inhibitors and anti-nausea agents

#25350
20050065152
2005-03-24

1-Adamantyl chalcones for the treatment of proliferative disorders

#25351
20050065133
2005-03-24

Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and an EP2 or EP4 selective agonist

#25352
20050065130
2005-03-24

Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and a cyclooxgenase-2 inhibitor

#25353
20050065126
2005-03-24

Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and aromatase inhibitors

#25354
20050065121
2005-03-24

Methods to increase plasma HDL cholesterol levels and improve HDL functionality with probucol monoesters

#25355
20050065117
2005-03-24

Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and a bisphosphonate

#25356
20050065114
2005-03-24

Therapeutical treatment with oligo-beta- (1,3) -glucans, drugs used in said treatment

#25357
20050065111
2005-03-24

Chemotherapeutic antineoplastic treatment

#25358
20050065110
2005-03-24

Pharmaceutically active uridine esters

#25359
20050065094
2005-03-24

Use of telmisartan for the prevention and treatment of vascular headache

#25360
20050065091
2005-03-24

Stabilized ocular solutions

#25361
20050065089
2005-03-24

TGF-beta activation and use

#25362
20050065088
2005-03-24

Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and parathyroid hormone

#25363
20050065087
2005-03-24

Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and a bone morphogenetic protein

#25364
20050065083
2005-03-24

Methods and compositions for the treatment of motor neuron injury and neuropathy

#25365
20050065066
2005-03-24

Stabilised insulin compositions

#25366
20050064541
2005-03-24

Interleukin-18 binding proteins, their preparation and use

#25367
20050064539
2005-03-24

Glycoprotein and process for producing the same

#25368
20050064070
2005-03-24

Beverage compositions for use in rehydration and nutrition during athletic exercise and methods of making same

#25369
20050064051
2005-03-24

Oral Rinse

#25370
20050064047
2005-03-24

Composition and method for treating skin disorders

#25371
20050064043
2005-03-24

Colon cleansing composition and method

#25372
20050064042
2005-03-24

Cartilage implant plug with fibrin glue and method for implantation

#25373
20050064032
2005-03-24

Dosage form, device, and methods of treatment

#25374
20050064031
2005-03-24

Combination contraceptive, kits that contain the latter, and a method that uses the latter

#25375
20050064028
2005-03-24

Pharmaceutical compositions containing plasma protein

#25376
20050064025
2005-03-24

Compositions and methods for treating, preventing and/or ameliorating cancers, the onset of cancers or the symptoms of cancers

#25377
20050064013
2005-03-24

Ready to drink beverage composition having liquid form HGH pre-cursor and method of making same

#25378
20050063997
2005-03-24

Ocular solutions

#25379
20050063996
2005-03-24

Ocular solutions

#25380
20050063992
2005-03-24

Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and an estrogen

#25381
20050063990
2005-03-24

Compositons and methods for weight loss

#25382
20050063976
2005-03-24

Combination therapy for treating disease

#25383
20050063950
2005-03-24

Systemic viral/ligand gene delivery system and gene therapy

#25384
20050063947
2005-03-24

Method for treating cancer in humans

#25385
20050063944
2005-03-24

Method of inducing maturation of dendritic cells and uses therefor

#25386
20050063932
2005-03-24

Skin care compositions including hexapeptide complexes and methods of their manufacture

#25387
20050063909
2005-03-24

Oral dosage form comprising a therapeutic agent and an adverse-effect agent

#25388
20050063903
2005-03-24

Combined use of cruciferous indoles and chelators for the treatment of papilloma virus-related conditions

#25389
20050061678
2005-03-24

Treatment of humans with colloidal silver composition

#25390
20050059802
2005-03-17

Prevention and treatment of amyloidogenic disease

#25391
20050059745
2005-03-17

Antiviral therapy

#25392
20050059744
2005-03-17

Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions

#25393
20050059743
2005-03-17

Methods for treating mild cognitive impairment and alzheimer's disease

#25394
20050059741
2005-03-17

Compositions and methods involving the combination of a thromboxane A2 receptor antagonist and an inhibitor of cyclooxygenase-1

#25395
20050059738
2005-03-17

Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion

#25396
20050059734
2005-03-17

Compositions comprising inhibitors of IMPDH enzyme

#25397
20050059720
2005-03-17

Medicinal compositions for the prevention or treatment of cardiac failure

#25398
20050059718
2005-03-17

Methods of using zonisamide as an adjunctive therapy for partial seizures

#25399
20050059715
2005-03-17

Combinations comprising alpha-2-delta ligands

#25400
20050059706
2005-03-17

Treatment of diabetes with thiazolidinedione and metformin

#25401
20050059704
2005-03-17

Compositions useful for treating gastrointestinal motility disorders

#25402
20050059703
2005-03-17

Diaryl ureas for diseases mediated by PDGFR

#25403
20050059697
2005-03-17

Combination of organic compounds

#25404
20050059690
2005-03-17

Method of treating acute pain with a unitary dosage form comprising ibuprofen and oxycodone

#25405
20050059688
2005-03-17

Use of tyrosine kinase inhibitors for treating inflammatory diseases

#25406
20050059682
2005-03-17

Compositions and methods for treatment of cancer

#25407
20050059674
2005-03-17

Method of treating middle ear infections

#25408
20050059666
2005-03-17

CCR5 antagonists useful for treating AIDS

#25409
20050059660
2005-03-17

Novel combination

#25410
20050059654
2005-03-17

Method for treatment of depression and anxiety disorders by combination therapy

#25411
20050059647
2005-03-17

Use of endoperoxides for the treatment of infections caused by flaviviridae, including hepatitis C, bovine viral diarrhea and classical swine fever virus

#25412
20050059644
2005-03-17

Dermatological compositions and methods

#25413
20050059643
2005-03-17

Medicaments for inhalation comprising a steroid and a betamimetic

#25414
20050059641
2005-03-17

Compositions and methods for treating and preventing cancer using analogs of vitamin D

#25415
20050059640
2005-03-17

Treatment for reactive arthritis or bursitis

#25416
20050059634
2005-03-17

Per-6-substituted-per-6-deoxy-cyclodextrins, and use of the same to inhibit soluble beta-amyloid-peptide derived oligomers and to treat alzheimer's and related diseases

#25417
20050059624
2005-03-17

Application of mRNA for use as a therapeutic agent for tumorous diseases

#25418
20050059620
2005-03-17

Promoter driven tissue specific cytotoxic agents and title methods of use

#25419
20050059616
2005-03-17

Therapeutic methods and compositions involving isoflavones

#25420
20050059601
2005-03-17

Exendins, exendin agonists, and methods for their use

#25421
20050059594
2005-03-17

Methods and compositions for producing a neurosalutary effect in a subject

#25422
20050059591
2005-03-17

Prevention and treatment of amyloidogenic disease

#25423
20050059589
2005-03-17

Methods and compositions for treating allergic reactions

#25424
20050059579
2005-03-17

Dietary and pharmaceutical compositions for management and treatment of oxidative stress

#25425
20050059578
2005-03-17

Compositions comprising phosphatidylethanolamine-binding peptides linked to anti-viral agents

#25426
20050059573
2005-03-17

Methods, compositions, and kits for organ protection during systemic anticancer therapy

#25427
20050059099
2005-03-17

PSCA: prostate stem cell antigen and uses thereof

#25428
20050058734
2005-03-17

Administration of capsaicinoids

#25429
20050058732
2005-03-17

Herbal pharmaceutical composition for treating siriasis and its process

#25430
20050058731
2005-03-17

Antimicrobial composition comprising soy oil, rice bran oil and jojoba oil

#25431
20050058730
2005-03-17

Compositions and methods for preventing or treating eyestrain

#25432
20050058729
2005-03-17

Treatment for bacterial infections and related disorders

#25433
20050058728
2005-03-17

Cytokine modulators and related method of use

#25434
20050058725
2005-03-17

Combination therapy including a matrix metalloproteinase inhibitor and an antineoplastic agent

#25435
20050058724
2005-03-17

Fluid therapy with l-lactate and/or pyruvate anions

#25436
20050058722
2005-03-17

Herbo-mineral formulation for refractory leukemias and lymphomas

#25437
20050058720
2005-03-17

Methods and compositions for the treatment of angiogenic diseases

#25438
20050058718
2005-03-17

Preparations for cigarette toxicity reduction, health enhancement, and addiction elimination

#25439
20050058702
2005-03-17

Compositions capable of facilitating penetration across a biological barrier

#25440
20050058696
2005-03-17

Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions

#25441
20050058673
2005-03-17

Antimicrobial compositions and methods

#25442
20050058672
2005-03-17

Baby Care Skin Protectant Compositions for Diaper Rash

#25443
20050058671
2005-03-17

Dietary supplement and method for treating digestive system-related disorders

#25444
20050058644
2005-03-17

Combination therapy of gamma-interferon and B-cell specific antibodies

#25445
20050058641
2005-03-17

Tolerance induction and maintenance in hematopoietic stem cell allografts

#25446
20050058636
2005-03-17

Medicament against thrombotic diseases

#25447
20050058628
2005-03-17

Nuclear reprogramming of cells for therapeutic use

#25448
20050058624
2005-03-17

Chimeric IL-10 proteins and uses thereof

#25449
20050058623
2005-03-17

Use of gp130 activators in diabetic neuropathy

#25450
20050058622
2005-03-17

Methods of using Flt3-Ligand in hematopoietic cell transplantation procedures incorporating nonmyeloablative conditioning regimens

#25451
20050054845
2005-03-10

Thymosin augmentation of genetic immunization

#25452
20050054731
2005-03-10

Multi-system therapy for diabetes, the metabolic syndrome and obesity

#25453
20050054728
2005-03-10

Immunoregulatory compounds and derivatives and methods of treating diseases therewith

#25454
20050054727
2005-03-10

Phenyl naphthol ligands for thyroid hormone receptor

#25455
20050054723
2005-03-10

Method for the treatment of glaucoma and ocular hypertension with prostaglandin analogues without melanogenic side effect

#25456
20050054719
2005-03-10

Dimeric compounds and their use as anti-viral agents

#25457
20050054718
2005-03-10

Dimeric compounds and their use as anti-viral agents

#25458
20050054708
2005-03-10

Combinations of drugs for the treatment of neoplasms

#25459
20050054702
2005-03-10

Method of controlling allergens

#25460
20050054687
2005-03-10

Treatment of diabetes with thiazolidinedione and sulphonylurea

#25461
20050054685
2005-03-10

Pharmaceutical composition

#25462
20050054682
2005-03-10

Pharmaceutical compositions comprising substituted benzimidazoles and methods of using same

#25463
20050054673
2005-03-10

Combination of phenylcarboxylic acid amides with beta-adrenoreceptor blockers and their use for the treatment of atrial arrhythmias

#25464
20050054672
2005-03-10

Quinolinone derivatives

#25465
20050054665
2005-03-10

Treatment for CD5+ B cell lymphoma

#25466
20050054663
2005-03-10

GSK-3 inhibitors

#25467
20050054651
2005-03-10

Compositions and methods for the treatment of disease associated with Trp-p8 expression

#25468
20050054647
2005-03-10

New pharmaceutical combination

#25469
20050054646
2005-03-10

Compositions of a cyclooxygenase-2 selective inhibitor and an antioxidant agent for the treatment of central nervous system disorders

#25470
20050054623
2005-03-10

Method for treating erectile dysfunction and increasing libido in men

#25471
20050054618
2005-03-10

Use of glycogen phosphorylase inhibitors for treatment of cardiovascular diseases

#25472
20050054617
2005-03-10

Use of potent, selective and non toxic c-kit inhibitors for treating mastocytosis

#25473
20050054606
2005-03-10

Method for prevention of neuropsychiatric disorders

#25474
20050054600
2005-03-10

Modified protein kinase a-specific oligonucleotides and methods of their use

#25475
20050054594
2005-03-10

Methods for particle-assisted polynucleotide immunization using a pulsed electric field

#25476
20050054589
2005-03-10

Method for treating diseases using HSP90-inhibiting agents in combination with antibiotics

#25477
20050054588
2005-03-10

Methods and compositions for the treatment of asthma and related disorders

#25478
20050054587
2005-03-10

Novel therapeutic indication of azithromycin for treatment of non-infective inflamatory diseases

#25479
20050054585
2005-03-10

Agent controlling the production of osteoclast formation regulator and method of screening substance capable of controlling the production of osteoclast formation regulator

#25480
20050054584
2005-03-10

Use of sugar phosphates, sugar phosphate analog, amino acids, amino acid analogs for modulating transaminases and/or the association of p36/ malate dehydrogenase

#25481
20050054580
2005-03-10

Methods for production of the oxidized glutathione composite with cis-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells

#25482
20050054568
2005-03-10

Angiogenesis-modulating compositions and uses

#25483
20050054558
2005-03-10

Methods and compositions for treating ocular disorders

#25484
20050054557
2005-03-10

Compositions for delivering parathyroid hormone and calcitonin

#25485
20050054556
2005-03-10

Antiphlogistic agent and the use thereof

#25486
20050053680
2005-03-10

Pediculicidal compound

#25487
20050053678
2005-03-10

Methods and compositions for betel nut chewing gum

#25488
20050053676
2005-03-10

Powdered composition for use as laxative

#25489
20050053675
2005-03-10

Method of making, and the use of cytotoxic agents containing elemental selenium

#25490
20050053674
2005-03-10

Pharmaceutical composition and method for retardation of the progression of atherosclerosis

#25491
20050053673
2005-03-10

Composition and method for facilitating bone healing

#25492
20050053670
2005-03-10

Composition for easing human childbirth

#25493
20050053664
2005-03-10

Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer

#25494
20050053661
2005-03-10

Pharmaceutical compositions comprising metformine and glibenclamide for the treatment of type II diabetes mellitus

#25495
20050053659
2005-03-10

Methods and compositions for reducing the risk associated with the administration of opioid analgesics in patients with diagnosed or undiagnosed respiratory illness

#25496
20050053641
2005-03-10

Method of treating irritable bowel syndrome

#25497
20050053625
2005-03-10

Method of treating viral infections

#25498
20050053619
2005-03-10

Composition and method for providing temporary relief of sinus pain and nasal congestion

#25499
20050053614
2005-03-10

Prevention and treatment of amyloidogenic disease

#25500
20050053613
2005-03-10

Enhanced immunization and suppression of oral tolerance